517 related articles for article (PubMed ID: 24641676)
1. Role of baseline antral follicle count and anti-Mullerian hormone in the index stimulation cycle of IVF treatment in predicting outcome of subsequent frozen-thawed embryo transfers.
Li HW; Lee VC; Lau EY; Yeung WS; Ho PC; Ng EH
Gynecol Endocrinol; 2014 Jul; 30(7):490-3. PubMed ID: 24641676
[TBL] [Abstract][Full Text] [Related]
2. Role of baseline antral follicle count and anti-Mullerian hormone in prediction of cumulative live birth in the first in vitro fertilisation cycle: a retrospective cohort analysis.
Li HW; Lee VC; Lau EY; Yeung WS; Ho PC; Ng EH
PLoS One; 2013; 8(4):e61095. PubMed ID: 23637787
[TBL] [Abstract][Full Text] [Related]
3. Predictive value of antral follicle count and serum anti-Müllerian hormone: Which is better for live birth prediction in patients aged over 40 with their first IVF treatment?
Lee Y; Kim TH; Park JK; Eum JH; Lee HJ; Kim J; Lyu SW; Kim YS; Lee WS; Yoon TK
Eur J Obstet Gynecol Reprod Biol; 2018 Feb; 221():151-155. PubMed ID: 29306180
[TBL] [Abstract][Full Text] [Related]
4. The use of anti-Müllerian hormone and antral follicle count to predict the potential of oocytes and embryos.
Majumder K; Gelbaya TA; Laing I; Nardo LG
Eur J Obstet Gynecol Reprod Biol; 2010 Jun; 150(2):166-70. PubMed ID: 20223579
[TBL] [Abstract][Full Text] [Related]
5. Anti-müllerian hormone levels are associated with live birth rates in ART, but the predictive ability of anti-müllerian hormone is modest.
Alson SSE; Bungum LJ; Giwercman A; Henic E
Eur J Obstet Gynecol Reprod Biol; 2018 Jun; 225():199-204. PubMed ID: 29738982
[TBL] [Abstract][Full Text] [Related]
6. Basal Serum Anti-Müllerian Hormone Level as a Predictor of Clinical Outcomes in Freezing-all Embryo Transfer Program.
Li XL; Huang R; Fang C; Liang XY
Curr Med Sci; 2018 Oct; 38(5):861-867. PubMed ID: 30341521
[TBL] [Abstract][Full Text] [Related]
7. Predictive values of anti-müllerian hormone, antral follicle count and ovarian response prediction index (ORPI) for assisted reproductive technology outcomes.
Ashrafi M; Hemat M; Arabipoor A; Salman Yazdi R; Bahman-Abadi A; Cheraghi R
J Obstet Gynaecol; 2017 Jan; 37(1):82-88. PubMed ID: 27976974
[TBL] [Abstract][Full Text] [Related]
8. Predicting the cumulative chance of live birth over multiple complete cycles of in vitro fertilization: an external validation study.
Leijdekkers JA; Eijkemans MJC; van Tilborg TC; Oudshoorn SC; McLernon DJ; Bhattacharya S; Mol BWJ; Broekmans FJM; Torrance HL;
Hum Reprod; 2018 Sep; 33(9):1684-1695. PubMed ID: 30085143
[TBL] [Abstract][Full Text] [Related]
9. Ovarian response and cumulative live birth rate of women undergoing in-vitro fertilisation who had discordant anti-Mullerian hormone and antral follicle count measurements: a retrospective study.
Li HW; Lee VC; Lau EY; Yeung WS; Ho PC; Ng EH
PLoS One; 2014; 9(10):e108493. PubMed ID: 25313856
[TBL] [Abstract][Full Text] [Related]
10. Use of ovarian reserve parameters for predicting live births in women undergoing in vitro fertilization.
Lukaszuk K; Kunicki M; Liss J; Lukaszuk M; Jakiel G
Eur J Obstet Gynecol Reprod Biol; 2013 Jun; 168(2):173-7. PubMed ID: 23485092
[TBL] [Abstract][Full Text] [Related]
11. Anti-Müllerian hormone versus antral follicle count for defining the starting dose of FSH.
Lan VT; Linh NK; Tuong HM; Wong PC; Howles CM
Reprod Biomed Online; 2013 Oct; 27(4):390-9. PubMed ID: 23953069
[TBL] [Abstract][Full Text] [Related]
12. Predictive value of anti-müllerian hormone, follicle-stimulating hormone and antral follicle count on the outcome of ovarian stimulation in women following GnRH-antagonist protocol for IVF/ET.
Tsakos E; Tolikas A; Daniilidis A; Asimakopoulos B
Arch Gynecol Obstet; 2014 Dec; 290(6):1249-53. PubMed ID: 25001569
[TBL] [Abstract][Full Text] [Related]
13. Circulating basal anti-Müllerian hormone levels as predictor of ovarian response in women undergoing ovarian stimulation for in vitro fertilization.
Nardo LG; Gelbaya TA; Wilkinson H; Roberts SA; Yates A; Pemberton P; Laing I
Fertil Steril; 2009 Nov; 92(5):1586-93. PubMed ID: 18930213
[TBL] [Abstract][Full Text] [Related]
14. Anti-Müllerian hormone (AMH) is a strong predictor of live birth in women undergoing assisted reproductive technology.
Lukaszuk K; Liss J; Kunicki M; Jakiel G; Wasniewski T; Woclawek-Potocka I; Pastuszek E
Reprod Biol; 2014 Sep; 14(3):176-81. PubMed ID: 25152514
[TBL] [Abstract][Full Text] [Related]
15. Antimüllerian hormone as a predictor of live birth following assisted reproduction: an analysis of 85,062 fresh and thawed cycles from the Society for Assisted Reproductive Technology Clinic Outcome Reporting System database for 2012-2013.
Tal R; Seifer DB; Wantman E; Baker V; Tal O
Fertil Steril; 2018 Feb; 109(2):258-265. PubMed ID: 29331235
[TBL] [Abstract][Full Text] [Related]
16. Serum antimüllerian hormone measurements with second generation assay at two distinct menstrual cycle phases for prediction of cycle cancellation, pregnancy and live birth after in vitro fertilization.
Rezende CP; Rocha AL; Dela Cruz C; Borges LE; Del Puerto HL; Reis FM
J Assist Reprod Genet; 2014 Oct; 31(10):1303-10. PubMed ID: 25015034
[TBL] [Abstract][Full Text] [Related]
17. Specific ranges of anti-Mullerian hormone and antral follicle count correlate to provide a prognostic indicator for IVF outcome.
Keane K; Cruzat VF; Wagle S; Chaudhary N; Newsholme P; Yovich J
Reprod Biol; 2017 Mar; 17(1):51-59. PubMed ID: 28132758
[TBL] [Abstract][Full Text] [Related]
18. Analysis of IVF/ICSI-FET Outcomes in Women With Advanced Endometriosis: Influence on Ovarian Response and Oocyte Competence.
Li A; Zhang J; Kuang Y; Yu C
Front Endocrinol (Lausanne); 2020; 11():427. PubMed ID: 32765424
[No Abstract] [Full Text] [Related]
19. Anti-Mullerian hormone is a better marker than inhibin B, follicle stimulating hormone, estradiol or antral follicle count in predicting the outcome of in vitro fertilization.
Kunt C; Ozaksit G; Keskin Kurt R; Cakir Gungor AN; Kanat-Pektas M; Kilic S; Dede A
Arch Gynecol Obstet; 2011 Jun; 283(6):1415-21. PubMed ID: 21562964
[TBL] [Abstract][Full Text] [Related]
20. A prospective, comparative analysis of anti-Müllerian hormone, inhibin-B, and three-dimensional ultrasound determinants of ovarian reserve in the prediction of poor response to controlled ovarian stimulation.
Jayaprakasan K; Campbell B; Hopkisson J; Johnson I; Raine-Fenning N
Fertil Steril; 2010 Feb; 93(3):855-64. PubMed ID: 19046583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
